News

Just a summary of all the news articles that we could source from different places. A good way to make an investment decision is also to look at how actively the company is engaging with news sources to keep them in the news. In this day and age its critical to have a media presence.

Date Title Source
2022-08-11 12:57:47 pm Acasti Pharma Inc. (ACST) CEO Jan D'Alvise on Q1 2023 Results - Earnings Call Transcript SeekingAlpha
Aug-11-22 07:00AM Acasti Pharma Reports First Quarter 2023 Operational Results GlobeNewswire
Aug-02-22 04:15PM Acasti Pharma to Report First Quarter 2023 Financial Results on Thursday, August 11, 2022 GlobeNewswire
Jul-27-22 08:00AM Acasti Pharma Announces Initiation of Pharmacokinetic Study for GTX-101, the Companys Drug Candidate for the Treatment of Postherpetic Neuralgia GlobeNewswire
Jul-07-22 08:55AM Acasti Pharma Inc. Discusses Year-End Results and Clinical Development Progress with The Stock Day Podcast Newsfile
Jun-22-22 06:10PM Acasti Pharma Announces Annual Grants of Performance Stock Options GlobeNewswire
Jun-21-22 08:00AM Acasti Pharma Reports Fiscal Year 2022 Operational Results GlobeNewswire
Jun-16-22 04:15PM Acasti Pharma Schedules Fiscal Year 2022 Business Update Conference Call GlobeNewswire
Jun-14-22 08:00AM Acasti Pharma Announces the Issuance of Additional Patents for GTX-104 and GTX-101 GlobeNewswire
May-23-22 04:15PM Acasti Pharma Inc. Retains Lytham Partners to Lead Strategic Investor Relations and Shareholder Communication Program PR Newswire
May-18-22 11:20AM Acasti Pharma's IV Hemorrhage Drug Candidate At Par With Oral Nimodipine Benzinga
May-18-22 07:30AM Acasti Pharma Announces Positive Results for Pharmacokinetic Bridging Study, With Intravenous GTX-104 Meeting All Endpoints GlobeNewswire
May-16-22 01:30PM Update: Acasti Pharma CEO to Present at Microcap Rodeos Spring into Action Best Ideas Virtual Conference on May 18th ACCESSWIRE
May-16-22 01:20PM 36 of the Best Ideas Companies to Present at the Spring into Action - Best Ideas Investor Conference on May 16th - 20th, 2022 ACCESSWIRE
May-12-22 08:00AM Acasti Pharma CEO to Present at Microcap Rodeo's Spring into Action Best Ideas Virtual Conference on May 16th ACCESSWIRE
May-06-22 09:02AM 10 Biotech Penny Stocks Redditors Love Insider Monkey
Apr-25-22 08:30AM Acasti Pharma to Present at the B. Riley Securities' 2022 Virtual Neuro & Ophthalmology Conference on April 28th GlobeNewswire
Mar-25-22 07:30AM Acasti Pharma Appoints Healthcare Industry Leader Michael L. Derby to its Board of Directors GlobeNewswire
Mar-22-22 07:30AM Acasti Pharma Announces Patents for GTX-104 in Europe, GTX-102 in the U.S. and GTX-101 in Japan GlobeNewswire
Mar-09-22 08:30AM Acasti Pharma CEO to Present at the 32nd Annual Oppenheimer Healthcare Conference on March 16th GlobeNewswire
Feb-28-22 08:30AM Acasti Pharma Celebrates Rare Disease Day GlobeNewswire
Feb-23-22 09:50AM New Strong Sell Stocks for February 23rd Zacks
Feb-22-22 09:09AM Acasti Pharma Inc. CEO, Jan D'Alvise, Is Featured on The Stock Day Podcast Newsfile
Feb-14-22 07:00AM Acasti Pharma Provides Business Update for the Third Quarter of Fiscal 2022 GlobeNewswire
Feb-07-22 08:30AM Acasti Pharma Schedules Third Quarter Fiscal 2022 Business Update Conference Call GlobeNewswire
Jan-03-22 08:30AM Acasti Pharma to Present at the H.C. Wainwright BioConnect 2022 Conference GlobeNewswire
Dec-23-21 10:49AM BLITF Stock: 7 Thing to Know About Mobile Gaming Play i3 Interactive as Shares Rocket Today InvestorPlace
Dec-22-21 03:40PM ACST Stock Price Predictions: Why One Analyst Sees Acasti Rocketing to $6 InvestorPlace
Dec-22-21 07:28AM Todays Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday InvestorPlace
Dec-21-21 04:57AM Market Sentiment Around Loss-Making Acasti Pharma Inc. (CVE:ACST) Simply Wall St.
Dec-02-21 07:00AM Acasti Pharma Announces Interim Data Meets All Primary Endpoints for Pivotal PK Study for GTX-104 GlobeNewswire
Nov-24-21 08:30AM Acasti Pharma CEO to Participate in the Benzinga All Access Event on December 2nd GlobeNewswire
Nov-12-21 05:34PM Acasti Pharma Announces Annual Stock Option Grants GlobeNewswire
Nov-11-21 08:30AM Acasti Pharma To Present At The Q4 Investor Summit on November 16th Newsfile
Nov-10-21 07:00AM Acasti Pharma Provides Business Update for the Second Quarter of Fiscal 2022 GlobeNewswire
Nov-04-21 08:30AM Acasti Pharma Schedules Second Quarter Fiscal 2022 Business Update Conference Call GlobeNewswire
Oct-07-21 10:15AM Monteverde & Associates PC Filed A Class Action Lawsuit On Behalf Of Shareholders Of Acasti Pharma, Inc. In The Southern District Of New York ACCESSWIRE
Oct-06-21 08:30AM Acasti Pharma Awarded Composition-of-Matter Patents for GTX-101 in Europe, China and Mexico and for GTX-102 in Japan GlobeNewswire
Sep-27-21 08:30AM Acasti Pharma Announces Initiation of Pharmacokinetic Bridging Study for GTX-104, the Companys Lead Drug Candidate for the Treatment of Subarachnoid Hemorrhage GlobeNewswire
Sep-22-21 08:30AM Acasti Pharma Provides Update Following Acquisition of Grace Therapeutics and Regains Compliance with Nasdaq Listing Standards GlobeNewswire
Sep-14-21 08:30AM Acasti Pharma to Present at the Oppenheimer Fall Healthcare Summit on September 21 GlobeNewswire
Sep-08-21 08:30AM Acasti Pharma to Present at the H.C. Wainwright 23rd Annual Global Investment Conference GlobeNewswire
Aug-31-21 02:27PM Why Shares of Acasti Pharma Slumped Tuesday Motley Fool
Aug-27-21 08:40AM Acasti Pharma Announces Successful Completion of its Merger with Grace Therapeutics, Inc., Voting Results of its Annual and Special Meeting of Shareholders and Reverse Stock Split GlobeNewswire
Aug-25-21 07:02AM 21 Stocks Moving in Wednesday's Pre-Market Session Benzinga
Aug-12-21 07:00AM Acasti Pharma Provides Business Update for the First Quarter of Fiscal 2022 GlobeNewswire
Jul-29-21 08:30AM Reminder: Acasti Pharma to Host Conference Call on August 4th at 1:00 PM ET to Discuss Planned Acquisition of Grace Therapeutics GlobeNewswire
Jul-23-21 08:30AM Acasti Pharma Schedules Conference Call for August 4th at 1:00 PM ET to Discuss Planned Acquisition of Grace Therapeutics GlobeNewswire
Jul-07-21 09:00AM INVESTIGATION ALERT: Halper Sadeh LLP Investigates RAVN, SHSP, ICBK, ACST; Shareholders are Encouraged to Contact the Firm GlobeNewswire
Jul-06-21 11:02AM SHAREHOLDER ALERT: Rigrodsky Law, P.A. Announces Investigation of Acasti Pharma Inc. Merger GlobeNewswire
Jul-03-21 06:52PM INVESTIGATION ALERT: Halper Sadeh LLP Investigates ACST, CLDR, DISCA, GRA, TRMT, XEC; Shareholders are Encouraged to Contact the Firm PR Newswire
Jul-03-21 12:14AM SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Acasti Pharma, Inc. - ACST PR Newswire
Jun-24-21 03:22AM Acasti Pharma Inc.'s (CVE:ACST) Shift From Loss To Profit Simply Wall St.
Jun-23-21 08:27AM Wednesdays Pre-Market: Heres What You Need to Know Before the Market Opens TipRanks
Jun-22-21 07:00AM Acasti Pharma Provides Fiscal 2021 Year-End Business Update GlobeNewswire
Jun-14-21 04:20PM 10 Best Biotech Penny Stocks to Buy Now Insider Monkey
May-17-21 07:00AM Acasti Intends to Request Hearing Before Nasdaq Panel to Present Plan of Compliance GlobeNewswire
May-13-21 06:05PM SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates UFS, FOE, CHMA, ACST; Shareholders are Encouraged to Contact the Firm PR Newswire
May-12-21 05:31PM ACASTI PHARMA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Acasti Pharma Inc. - ACST Business Wire
May-07-21 11:53AM Acasti Pharma To Acquire Grace Therapeutics: Highlights Benzinga
May-07-21 11:14AM Acasti Pharma Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Merger of Acasti Pharma Inc. Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm ACST Business Wire
May-07-21 07:00AM Acasti Announces Definitive Agreement to Acquire Grace Therapeutics, Inc. GlobeNewswire
Mar-08-21 05:30PM Acasti Pharma Provides Update on Recent Financing Activities GlobeNewswire
Feb-09-21 06:55AM Acasti Pharma Announces Results for Third Quarter of Fiscal 2021 GlobeNewswire
Jan-27-21 06:55AM Acasti Pharma Provides Update on Recent Financing Activities GlobeNewswire
Dec-25-20 12:00PM Acasti (ACST) Moves to Buy: Rationale Behind the Upgrade Zacks
Dec-23-20 03:24PM Acasti Pharma Unaware of Any Material Change GlobeNewswire
Nov-16-20 06:55AM Acasti Pharma Provides Business Update for the Second Quarter of Fiscal 2021 GlobeNewswire
Nov-12-20 05:43AM Here's Why Acasti Pharma (CVE:ACST) Must Use Its Cash Wisely Simply Wall St.
Oct-01-20 04:30PM Acasti Pharma Announces the Election of Its Directors, Advisory Resolution Approving Compensation, Amendments to Its Stock Option and Equity Incentive Plans, Adoption of Amended & Restated General By-Law and Other Related Matters Approved at Its AGM GlobeNewswire
Sep-29-20 06:55AM Acasti Announces Review Process of Strategic Alternatives GlobeNewswire
Sep-16-20 06:55AM Acasti Appoints Seasoned Executive Brian D. Ford CPA-CA as Chief Financial Officer GlobeNewswire
Sep-11-20 07:00AM Acasti Announces Filing and Mailing of Information Circular and Change in Record Date GlobeNewswire
Sep-01-20 02:10PM Acasti Pharma Stock Loses a Wall Street Supporter TipRanks
Aug-31-20 07:00AM Acasti Pharma Reports Topline Triglyceride Results from Phase 3 TRILOGY 2 Study of CaPre in Patients with Severe Hypertriglyceridemia GlobeNewswire
Aug-14-20 12:00PM What Makes Acasti (ACST) a New Buy Stock Zacks
Aug-13-20 08:30AM Acasti Pharma Provides Business Update for the First Quarter of Fiscal 2021 GlobeNewswire
Jul-31-20 07:55AM Acasti Pharma Submits Statistical Analysis Plan to FDA and Remains On Track to Report TRILOGY 2 Topline Data On or About August 31, 2020 GlobeNewswire
Jul-06-20 02:37PM Why Acasti Pharma's Stock Is Trading Higher Today Benzinga
Jun-29-20 09:45AM Acasti Pharma Provides Fiscal 2020 Year-End Business Update GlobeNewswire
Jun-19-20 08:00AM Acasti Pharma Receives FDA Response to TRILOGY 1 Briefing Package GlobeNewswire
Jun-04-20 09:49PM Hedge Funds Souring On Acasti Pharma Inc. (ACST) Insider Monkey
May-06-20 06:25AM Does The Acasti Pharma Inc. (CVE:ACST) Share Price Fall With The Market? Simply Wall St.
Apr-30-20 08:30AM Acasti Pharma Announces Submission of TRILOGY 1 Briefing Package to FDA GlobeNewswire
Apr-20-20 08:30AM Acasti Pharma Awarded Notice of Allowance for Second Composition of Matter Patent in Canada GlobeNewswire
Apr-01-20 08:30AM Acasti Pharma Submits FDA Meeting Request on Schedule, and FDA Meeting Expected in the Second Half of June GlobeNewswire
Mar-11-20 08:00AM Acasti Pharma Awarded Notice of Allowance for Additional Composition of Matter and Method of Use Patents in the United States and Mexico GlobeNewswire
Mar-06-20 06:50AM Amarin Stock Looks Like a Heart-Healthy Buy on the Dip InvestorPlace
Feb-28-20 05:00PM Acasti Receives NASDAQ Notification Regarding Minimum Bid Requirements GlobeNewswire
Feb-28-20 02:48PM Look Anywhere but Acasti Pharma Stock for Opportunity InvestorPlace
Feb-28-20 10:07AM Confounding Decline Creates an Opportunity in Amarin Stock InvestorPlace
Feb-14-20 11:41AM Risks Remain, but Amarin Stock Is a Buy at Todays Prices InvestorPlace
Feb-14-20 08:00AM Acasti Pharma Provides Business Update for the Third Quarter of Fiscal 2020 GlobeNewswire
Feb-13-20 09:00AM Acasti Pharma Schedules Third Quarter Fiscal 2020 and Business Update Conference Call GlobeNewswire
Feb-11-20 11:27AM 3 Beaten-Down Biotech Stocks With +50% Upside Potential TipRanks
Feb-11-20 07:23AM The Daily Biotech Pulse: LogicBio Slapped With Clinical Hold, Agile Inks Debt Deal Ahead of Twirla Approval, Gilead Builds Stake In Sierra Oncology Benzinga
Feb-10-20 07:00AM Acasti Pharma Provides Update on TRILOGY 1 and TRILOGY 2 Phase 3 Trials of CaPre GlobeNewswire
Jan-17-20 11:07AM Does Acasti Stock Have a Future? InvestorPlace
Jan-17-20 06:30AM Why Amarin Stock Is Poised for a Healthy 2020 InvestorPlace
Jan-14-20 09:46AM AstraZeneca to End Phase III Study on Fish Oil Heart Drug Zacks
Jan-14-20 07:55AM The Daily Biotech Pulse: PhaseBio To Buy Hypertension Asset, Stemline Falls On Q4 Pre-Announcement, FDA Panel To Review Nektar's Opioid Drug Benzinga